About Tulane/LSU Maternal/Child CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
34
Clinical Trials at Tulane/LSU Maternal/Child CRS
During the past decade, Tulane/LSU Maternal/Child CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
1995-11-01
Completed
2,100
A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
1995-06-01
Completed
140
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
1998-06-01
Completed
96
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
1998-04-01
Completed
158
A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection
1996-02-01
Completed
72
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
1996-09-01
Completed
24
A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
1999-01-01
Completed
156
A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection
1998-07-01
Completed
230
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane/LSU Maternal/Child CRS"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Glaxo Wellcome" with 4 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Tulane/LSU Maternal/Child CRS
According to Clinical.Site data, the most researched conditions in "Tulane/LSU Maternal/Child CRS" are
"HIV Infections" (34 trials), "Pneumonia, Pneumocystis Carinii" (4 trials), "Pregnancy" (3 trials), "Cervix, Dysplasia" (2 trials) and "Cytomegalovirus Infections" (1 trials). Many other conditions were trialed in "Tulane/LSU Maternal/Child CRS" in a lesser frequency.
Clinical Trials Intervention Types at Tulane/LSU Maternal/Child CRS
Most popular intervention types in "Tulane/LSU Maternal/Child CRS" are "Drug" (26 trials), "Biological" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (9 trials), "Didanosine" (5 trials), "Lamivudine" (5 trials), "Nelfinavir mesylate" (4 trials) and "Stavudine" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Tulane/LSU Maternal/Child CRS
The vast majority of trials in "Tulane/LSU Maternal/Child CRS" are
29 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Tulane/LSU Maternal/Child CRS
Currently, there are NaN active trials in "Tulane/LSU Maternal/Child CRS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in Tulane/LSU Maternal/Child CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tulane/LSU Maternal/Child CRS, 17 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".